Published in J Virol on September 05, 2012
An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response. J Virol (2014) 0.86
PB2 segment promotes high-pathogenicity of H5N1 avian influenza viruses in mice. Front Microbiol (2015) 0.78
Antigenic mapping of an H9N2 avian influenza virus reveals two discrete antigenic sites and a novel mechanism of immune escape. Sci Rep (2016) 0.77
Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance. PLoS Comput Biol (2016) 0.75
An NS-segment exonic splicing enhancer regulates influenza A virus replication in mammalian cells. Nat Commun (2017) 0.75
Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol (2001) 21.17
Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 13.48
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
The multifunctional NS1 protein of influenza A viruses. J Gen Virol (2008) 6.87
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity (2001) 5.04
Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine (2002) 4.45
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A (2000) 3.95
Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J (1994) 3.26
The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev (1994) 2.64
Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol (2007) 2.44
Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J Virol (1998) 2.42
Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J (2003) 2.38
Suppression of the antiviral response by an influenza histone mimic. Nature (2012) 2.18
Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J Virol (1995) 2.16
NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J Gen Virol (2009) 2.16
NS1 protein of influenza A virus down-regulates apoptosis. J Virol (2002) 2.12
Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway. J Virol (2000) 2.11
Influenza virus NS1 protein stimulates translation of the M1 protein. J Virol (1994) 2.05
Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat Struct Biol (1997) 2.02
Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Res (2006) 1.96
Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J (2003) 1.95
Caspases disrupt the nuclear-cytoplasmic barrier. J Cell Biol (2000) 1.84
Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol (2005) 1.78
Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J Biochem (1996) 1.77
Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol (2006) 1.77
Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes. J Virol (2005) 1.67
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J Virol (2002) 1.63
Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology (2011) 1.62
Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis (2007) 1.61
Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol (1999) 1.61
Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J Virol (1995) 1.46
Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol (2004) 1.44
Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J Gen Virol (2007) 1.38
The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J Interferon Cytokine Res (1999) 1.24
Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. J Virol (1995) 1.21
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J Infect Dis (2010) 1.18
Genomic and protein structural maps of adaptive evolution of human influenza A virus to increased virulence in the mouse. PLoS One (2011) 1.13
Attenuated influenza virus vaccines with modified NS1 proteins. Curr Top Microbiol Immunol (2009) 1.08
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One (2009) 1.04
Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J Virol (2010) 1.00
The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein. J Gen Virol (2011) 1.00
Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants. Int J Cancer (2004) 0.98
High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol (2010) 0.96
NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J Virol (2010) 0.95
Characterization of the mutations responsible for the electrophoretic mobility differences in the NS proteins of vesicular stomatitis virus New Jersey complementation group E mutants. J Gen Virol (1986) 0.91
Attenuated influenza virus construct with enhanced hemagglutinin protein expression. J Virol (2012) 0.86
Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency. J Virol (2010) 0.85
Structure-based design of NS2 mutants for attenuated influenza A virus vaccines. Virus Res (2010) 0.85
Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One (2011) 0.85
Identification of cellular partners of Influenza A virus (H5N1) non-structural protein NS1 by yeast two-hybrid system. Acta Virol (2009) 0.84
Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate. Vaccine (2009) 0.84
Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Appl Microbiol Biotechnol (2011) 0.84
Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness. PLoS One (2011) 0.83
Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. J Virol Methods (2010) 0.82
Inefficient splicing of segment 7 and 8 mRNAs is an inherent property of influenza virus A/Brevig Mission/1918/1 (H1N1) that causes elevated expression of NS1 protein. Virology (2011) 0.80
MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres. Vaccine (2011) 0.80
Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta (1999) 2.20
Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: measurement and modeling. Biotechnol Bioeng (2004) 1.50
The viral replication complex is associated with the virulence of Newcastle disease virus. J Virol (2010) 1.24
Acetate as a carbon source for hydrogen production by photosynthetic bacteria. J Biotechnol (2001) 1.16
Cell kinetics of the marine sponge Halisarca caerulea reveal rapid cell turnover and shedding. J Exp Biol (2009) 1.10
Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine (2010) 1.06
Insect cells for human food. Biotechnol Adv (2006) 1.05
Autographa californica baculoviruses with large genomic deletions are rapidly generated in infected insect cells. Virology (2001) 1.03
Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine (2012) 1.01
Re-plumbing in a Mediterranean sponge. Biol Lett (2007) 1.01
Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J Virol (2012) 1.00
Virulence of pigeon paramyxovirus type 1 does not always correlate with the cleavability of its fusion protein. J Gen Virol (2009) 0.99
The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Biomaterials (2004) 0.97
Low oxygen tension stimulates the redifferentiation of dedifferentiated adult human nasal chondrocytes. Osteoarthritis Cartilage (2004) 0.97
Selective extraction of carotenoids from the microalga Dunaliella salina with retention of viability. Biotechnol Bioeng (2002) 0.97
Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. Vaccine (2002) 0.97
Passaging of a Newcastle disease virus pigeon variant in chickens results in selection of viruses with mutations in the polymerase complex enhancing virus replication and virulence. J Gen Virol (2010) 0.97
Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. Vaccine (2010) 0.96
Expansion of bovine chondrocytes on microcarriers enhances redifferentiation. Tissue Eng (2003) 0.96
Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease. Int J Parasitol (2001) 0.96
Determinants of virulence of classical swine fever virus strain Brescia. J Virol (2004) 0.95
Modelling the interactions between Lactobacillus curvatus and Enterobacter cloacae. II. Mixed cultures and shelf life predictions. Int J Food Microbiol (1999) 0.95
Mechanism of extraction of beta-carotene from microalga Dunaliellea salina in two-phase bioreactors. Biotechnol Bioeng (2004) 0.94
Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. Vaccine (2010) 0.94
Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J Virol (2012) 0.94
The effect of PEGT/PBT scaffold architecture on the composition of tissue engineered cartilage. Biomaterials (2005) 0.93
Time dependent responses of glycolytic intermediates in a detailed glycolytic model of Lactococcus lactis during glucose run-out experiments. Mol Biol Rep (2002) 0.93
Milking microalga Dunaliella salina for beta-carotene production in two-phase bioreactors. Biotechnol Bioeng (2004) 0.92
Influence of maternal antibodies on efficacy of a subunit vaccine: transmission of classical swine fever virus between pigs vaccinated at 2 weeks of age. Vaccine (2002) 0.92
Modeling the interactions of Lactobacillus curvatus colonies in solid medium: consequences for food quality and safety. Appl Environ Microbiol (2002) 0.91
Efficiency of light utilization of Chlamydomonas reinhardtii under medium-duration light/dark cycles. J Biotechnol (2000) 0.91
Effect of light intensity on beta-carotene production and extraction by Dunaliella salina in two-phase bioreactors. Biomol Eng (2003) 0.88
Serological evidence indicates that foot-and-mouth disease virus serotype O, C and SAT1 are most dominant in eritrea. Transbound Emerg Dis (2013) 0.87
A comparative infection study of pigeon and avian paramyxovirus type 1 viruses in pigeons: evaluation of clinical signs, virus shedding and seroconversion. Avian Pathol (2011) 0.86
Effect of mixing rate on beta-carotene production and extraction by dunaliella salina in two-phase bioreactors. Biotechnol Bioeng (2003) 0.86
Optimization of a feed medium for fed-batch culture of insect cells using a genetic algorithm. Biotechnol Bioeng (2003) 0.86
Biofilm growth of Chlorella sorokiniana in a rotating biological contactor based photobioreactor. Biotechnol Bioeng (2014) 0.86
Dynamics of artificially immobilized Nitrosomonas europaea: Effect of biomass decay. Biotechnol Bioeng (1997) 0.85
Nitrogen and phosphorus removal from municipal wastewater effluent using microalgal biofilms. Water Res (2011) 0.84
Primmorphs from seven marine sponges: formation and structure. J Biotechnol (2003) 0.84
Ratio between autoflocculating and target microalgae affects the energy-efficient harvesting by bio-flocculation. Bioresour Technol (2012) 0.82
Nutrient removal and biomass production in an outdoor pilot-scale phototrophic biofilm reactor for effluent polishing. Appl Biochem Biotechnol (2013) 0.82
Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. J Virol Methods (2010) 0.82
Growth of oil accumulating microalga Neochloris oleoabundans under alkaline-saline conditions. Bioresour Technol (2011) 0.82
Tissue tropism in the chicken embryo of non-virulent and virulent Newcastle diseases strains that express green fluorescence protein. Avian Pathol (2003) 0.81
Growth inhibition of Monodus subterraneus by free fatty acids. Biotechnol Bioeng (2008) 0.81
Vertical transmission of Rift Valley fever virus without detectable maternal viremia. Vector Borne Zoonotic Dis (2013) 0.80
Simultaneous nitrification and denitrification using immobilized microorganisms. Biomater Artif Cells Immobilization Biotechnol (1993) 0.80
Effect of oxygen tension on adult articular chondrocytes in microcarrier bioreactor culture. Tissue Eng (2004) 0.80
Cell cultures from the symbiotic soft coral Sinularia flexibilis. In Vitro Cell Dev Biol Anim (2008) 0.80
Growth and substrate consumption of Nitrobacter agilis cells immobilized in carrageenan: part 1. Dynamic modeling. Biotechnol Bioeng (1991) 0.80
MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres. Vaccine (2011) 0.80
Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers. Vaccine (2011) 0.79
VP1, the RNA-dependent RNA polymerase and genome-linked protein of infectious bursal disease virus, interacts with the carboxy-terminal domain of translational eukaryotic initiation factor 4AII. Arch Virol (2004) 0.79
A practical approach for exploration and modeling of the design space of a bacterial vaccine cultivation process. Biotechnol Bioeng (2009) 0.78
Effect of low inoculation density in the scale-up of insect cell cultures. Biotechnol Prog (2000) 0.78
Effects of mutations in the VP2/VP4 cleavage site of Swine vesicular disease virus on RNA encapsidation and viral infectivity. Arch Virol (2003) 0.78
Growth of Ca-D-malate crystals in a bioreactor. Biotechnol Bioeng (2000) 0.78
Dimerization of glycoprotein E(rns) of classical swine fever virus is not essential for viral replication and infection. Arch Virol (2005) 0.77
Energy budget for the cultured, zooxanthellate octocoral Sinularia flexibilis. Mar Biotechnol (NY) (2011) 0.77
Relevance of rheological properties of gel beads for their mechanical stability in bioreactors. Biotechnol Bioeng (1997) 0.77
Light-dependency of growth and secondary metabolite production in the captive zooxanthellate soft coral Sinularia flexibilis. Mar Biotechnol (NY) (2008) 0.76
Immobilized salt-tolerant yeasts: application of a new polyethylene-oxide support in a continuous stirred-tank reactor for flavour production. J Biotechnol (2001) 0.76
Development of in vivo sponge cultures: particle feeding by the tropical sponge Pseudosuberites aff. andrewsi. Mar Biotechnol (NY) (2001) 0.76
Immobilized soy-sauce yeasts: development and characterization of a new polyethylene-oxide support. J Biotechnol (2000) 0.75
Cultivation of the hybridoma cell line MN12 in a homogeneous continuous culture system: effect of culture age. Cytotechnology (1993) 0.75
Transplacental transmission of BTV-8 in sheep: BTV viraemia, antibody responses and vaccine efficacy in lambs infected in utero. Vaccine (2013) 0.75
Expression of the house dust mite allergen Der p 2 in the baker's yeast Saccharomyces cerevisiae. Clin Exp Allergy (1998) 0.75
Modeling solid-to-solid biocatalysis: integration of six consecutive steps. Biotechnol Bioeng (2000) 0.75
Kinetics and performance of a co-immobilised system of amyloglucosidase and Zymomonas mobilis. Biotechnol Bioeng (1999) 0.75
Effect of natural and chimeric haemagglutinin genes on influenza A virus replication in baby hamster kidney cells. J Biotechnol (2012) 0.75
Effect of growth phase on harvesting characteristics, autoflocculation and lipid content of Ettlia texensis for microalgal biodiesel production. Bioresour Technol (2013) 0.75
Calorimetric control of fed-batch fermentations. Biotechnol Bioeng (1990) 0.75
D-malate production by permeabilized Pseudomonas pseudoalcaligenes; optimization of conversion and biocatalyst productivity. J Biotechnol (2000) 0.75
Rheological properties and mechanical stability of new gel-entrapment systems applied in bioreactors. Biotechnol Bioeng (2000) 0.75
Estimation of steady-state culture characteristics during acceleration-stats with yeasts. Biotechnol Bioeng (2001) 0.75
Modeling microalgal flocculation and sedimentation. Bioresour Technol (2013) 0.75
[A case of very serious Sarcoptes mange in alpacas (Lama pacos)]. Tijdschr Diergeneeskd (2006) 0.75